Vera Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Vera Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Vera Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Vera Therapeutics Inc. is VERA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Vera Therapeutics Inc. has its primary listing on NASDAQ. You can trade Vera Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Vera Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Vera Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Vera Therapeutics Inc..